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Cummins TD, Holden CR, Sansbury BE, Gibb AA, Shah J,
Zafar N, Tang Y, Hellmann J, Rai SN, Spite M, Bhatnagar A, Hill
BG. Metabolic remodeling of white adipose tissue in obesity. Am J
Physiol Endocrinol Metab 307: E262–E277, 2014. First published
June 10, 2014; doi:10.1152/ajpendo.00271.2013.—Adipose tissue
metabolism is a critical regulator of adiposity and whole body energy
expenditure; however, metabolic changes that occur in white adipose
tissue (WAT) with obesity remain unclear. The purpose of this study
was to understand the metabolic and bioenergetic changes occurring
in WAT with obesity. Wild-type (C57BL/6J) mice fed a high-fat diet
(HFD) showed significant increases in whole body adiposity, had
significantly lower V̇O2, V̇CO2, and respiratory exchange ratios, and
demonstrated worsened glucose and insulin tolerance compared with
low-fat-fed mice. Metabolomic analysis of WAT showed marked
changes in lipid, amino acid, carbohydrate, nucleotide, and energy
metabolism. Tissue levels of succinate and malate were elevated, and
metabolites that could enter the Krebs cycle via anaplerosis were
mostly diminished in high-fat-fed mice, suggesting altered mitochondrial metabolism. Despite no change in basal oxygen consumption or
mitochondrial DNA abundance, citrate synthase activity was decreased by more than 50%, and responses to FCCP were increased in
WAT from mice fed a high-fat diet. Moreover, Pgc1a was downregulated and Cox7a1 upregulated after 6 wk of HFD. After 12 wk of
high-fat diet, the abundance of several proteins in the mitochondrial
respiratory chain or matrix was diminished. These changes were
accompanied by increased Parkin and Pink1, decreased p62 and
LC3-I, and ultrastructural changes suggestive of autophagy and mitochondrial remodeling. These studies demonstrate coordinated restructuring of metabolism and autophagy that could contribute to the
hypertrophy and whitening of adipose tissue in obesity.
metabolomics; insulin resistance; adipocyte; autophagy; mitochondria

is a principal health
concern worldwide. In 2008, approximately 1.5 billion adults
aged 20 yr or older were overweight, and 10% were obese (2).
In the US, more than one-third of the adult population is
currently obese (BMI ⬎30), and 68% have a BMI of ⬎25 (17).
By 2025, these numbers are expected to increase by more than
50% (70). These statistics are a cause for alarm. Obesity is a
powerful predictor of insulin resistance (51) and a major risk
factor for several common medical conditions such as type 2
diabetes, cardiovascular disease, nonalcoholic fatty liver disease, gallstones, Alzheimer’s disease, and cancers such as
breast, colon, endometrial, and esophageal cancer (21).

THE INCREASING PREVALENCE OF OBESITY
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Although lack of exercise is an undeniable risk factor for
weight gain (21, 27, 50), excessive caloric intake appears to be
one of the key factors fueling the obesity epidemic. In the past
three decades, the average consumption of calories in the US
has increased by ⱖ200 kcal/day per person, which could be
partly attributable to an increase in the intake of energy-dense
foods (7, 29, 40, 77). Such poor dietary habits negatively affect
metabolic homeostasis, which could not only promote obesity
but hasten the development of obesity-related comorbidities as
well. Despite the simplicity of the apparent remedy (i.e.,
decreasing caloric intake), treatment of obesity remains a
challenging crisis facing the health care system. The efficacy of
losing weight via caloric restriction is limited by multiple
challenges. These include an evolutionarily engendered guard
against starvation and low fat mass (70, 78) and a propensity to
increase caloric efficiency during dieting (34, 47). Although
drugs with anorectic and antiobesogenic properties are in
clinical use, many of these show marginal long-term efficacy
or have unacceptable or overtly dangerous side effects. Thus,
recent strategies to modulate obesity have begun to target
tissues that naturally regulate energy metabolism (70).
Increasing energy expenditure by modulating adipose tissue
activity could be an attractive target for therapy. Because adult
humans maintain small depots of brown fat that are capable of
burning significant amounts of caloric energy (16, 53, 72, 75),
multiple studies have focused on the physiological and molecular mechanisms regulating the thermogenic capacity of adipose tissue. These studies have shown that adaptive thermogenesis in brown fat can be a powerful regulator of systemic
energy metabolism. However, the relatively small amount of
brown adipose (⬍0.4% of body weight) compared with white
adipose tissue (WAT; which can comprise ⬎40% of the body
weight of an obese human) suggests that WAT may be a more
tangible target. Interestingly, white adipose depots, which
typically function to esterify free fatty acids and store excess
lipids, have the capacity to develop into brown adipose-like
tissue that is capable of modulating systemic metabolism and
preventing obesity and insulin resistance (65).
Although the phenomenon of adipose tissue “browning” is
an active area of research, there is also considerable interest in
understanding the metabolic changes that occur in WAT with
obesity. It is becoming increasingly clear that conditions of
nutrient excess promote “whitening” of adipose tissue characterized by a decrease in mitochondrial abundance (6, 14, 68).
Hence, although promoting browning is one way to positively
modulate metabolism, decreasing adipose tissue whitening
could be another strategy to prevent dysregulation of systemic
metabolism during obesity. Indeed, the beneficial metabolic
changes induced by drugs such as rosiglitazone and pioglita-
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zone have been suggested to be due in part to their ability to
prevent loss of mitochondria or increase mitochondrial function in WAT (6, 79). Nevertheless, mitochondrial changes in
WAT during the development of obesity have not been thoroughly examined, and it remains unclear how changes in
adipocyte metabolism affect adipocyte hypertrophy and metabolic homeostasis.
In this study, we examined WAT-specific changes in metabolism in a mouse model of diet-induced obesity. Our data
indicate extensive metabolic remodeling of WAT that precedes
both the infiltration of inflammatory cells and overt decreases
in mitochondrial abundance. This renovation of adipocyte
metabolism involved changes in glucose and lipid pathways
that appear to favor fat storage and prevent excessive lipid
oxidation. The metabolite profile also yields evidence of osmotic stress and adipocyte inflammation. Restructuring of
intermediary metabolism was accompanied by biochemical
and ultrastructural evidence of autophagy, which may promote
degradation of mitochondria. These findings have important
implications for understanding the metabolic effects of obesity
on adipose tissue metabolism and suggest that targeting metabolic pathways that contribute to adipose tissue whitening or
hypertrophy could form the basis for novel therapies to combat
metabolic disease.
METHODS

Animal studies. All procedures were approved by the University of
Louisville Institutional Animal Care and Use Committee. C57BL/6J
[wild-type (WT)] mice were purchased from The Jackson Laboratory
(Bar Harbor, ME). At 8 wk of age, male mice were placed on either
a 10% low-fat diet (LFD) (no. D12450B; Research Diets) or a 60%
high-fat diet (HFD) (no. D12492; Research Diets) for 6 or 12 wk.
Water and diet were provided ad libitum. Body weights were recorded
weekly.
Metabolic phenotyping. Body composition was measured by dualenergy X-ray absorptiometry using a mouse densitometer (PIXImus2;
Lunar, Madison, WI), and whole body energy expenditure, respiratory
exchange ratio, food consumption, and locomotion, ambulatory, and
fine movements were measured using a physiological/metabolic cage
system (TSE PhenoMaster System, Bad Homberg, Germany) (54).
Glucose and insulin tolerance tests and plasma levels of insulin were
measured exactly as described by Sansbury et al. (54).
Adipocyte size measurements. Adipose tissue was excised at the
time of euthanization, and wet weight was recorded. All adipose tissue
was either snap-frozen at ⫺80°C or fixed in 10% formalin, paraffin
embedded, and sectioned. The sections were stained in hematoxylin
and eosin. Adipocyte cross-sectional area and distribution were determined using Nikon Elements software. Adipose tissue sections
were assessed for crown-like structures, as described previously (22).
Adipose tissue metabolite profiling. WAT from the epididymal fat
pads of mice fed LFD or HFD for 6 wk was used for these analyses.
Prior to tissue collection, the mice were fasted for 16 h. After
euthanization, the adipose tissue was removed and immediately snapfrozen in liquid nitrogen. Relative metabolite abundance was then
measured by gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry, as described before (54, 55). Metabolites with missing values were imputed by replacing missing values
with half of the minimum positive value in the original data. After a
generalized logarithm transformation, the data were autoscaled, i.e.,
mean-centered and divided by the standard deviation of each variable.
This step was performed to transform the intensity values so that the
distribution was more Gaussian. Univariate (e.g., volcano plots),
multivariate [e.g., partial least squares-discriminant analysis (PLSDA)], and cluster (heatmap and dendogram) analyses were then
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performed. Most analyses were performed using Metaboanalyst 2.0
software (http://www.metaboanalyst.ca/) (82); z-score plots were constructed in GraphPad 5.0 software.
Adipose tissue bioenergetic measurements. The oxygen consumption rate (OCR) of intact WAT explants was measured using a
Seahorse XF24 analyzer (Seahorse Bioscience, Billerica, MA), as
described previously (54). At least two replicates from each animal
were used for the assay. After baseline measurements, the maximal
OCR was measured by exposing the explants to FCCP (10 M). The
nonmitochondrial OCR was measured following injection of antimycin A (25 M) and rotenone (5 M).
Citrate synthase activity assay. Citrate synthase assay was performed in 100 mM Tris·HCl, pH 8.0, containing 1 mM EDTA, 1 mM
5=,5=-dithiobis 2-nitrobenzoic acid, and 10 mM acetyl-CoA. The
reaction was initiated by the addition of 10 mM oxaloacetate. Cuvettes
were warmed to 37°C, and upon addition of 10 g of protein from
WAT lysates, absorbance at 420 nm was measured for 10 min.
Activity is expressed as nanomoles per minute per microgram of
protein.
Expression analyses. For quantitative RT-PCR, RNA was extracted
from tissues using the RNeasy lipid tissue kit (Qiagen), followed by
cDNA synthesis. Real-time PCR amplification was performed with
SYBR Green quantitative PCR (qPCR) Master Mix (SA Biosciences)
using a 7900HT Fast Real-Time PCR System (Applied Biosystems)
and primers for Il1, Tnfa, Il6, Arg1, Il10, Ym1, Hif1a, Emr1, Pgc1a,
Cytc, Sirt1, Sirt3, Pdk4, Cpt1a, Cpt1b, Cox7a1, Hprt, and Idh3a (IDT
Bioscience). Relative expression was determined by the 2⫺⌬⌬CT
method. M1 macrophages in WAT were measured by flow cytometry,
as described previously (22).
For measuring protein abundance, WAT homogenates were prepared as described in Horrillo et al. (25). Equal amounts of protein
were separated by SDS-PAGE, electroblotted to PVDF membranes,
and probed using primary antibodies according to the respective
manufacturers’ protocols. The following antibodies were used: aldehyde dehydrogenase 2 (ALDH2; Abcam), sirtuin 3 (Sirt3; Cell Signaling Technology), MitoProfile Total OXPHOS Rodent WB Antibody Cocktail (Mitosciences), COX4I1 (Cell Signaling Technology),
GAPDH (Cell Signaling Technology), Parkin (Abcam), Pink1 (Cell
Signaling Technology), p62 (Cell Signaling Technology), LC3 (Cell
Signaling Technology), protein-ubiquitin (Cell Signaling Technology), and ␣-tubulin (Sigma). Fluorescent or horseradish peroxidaselinked secondary antibodies (Invitrogen or Cell Signaling Technology, respectively) were used to detect and visualize the protein bands
with a Typhoon 9400 variable mode imager (GE Healthcare). Band
intensity was quantified using Image Quant TL software.
Relative mitochondrial DNA measurements. Mitochondrial abundance in adipose tissue was estimated by measuring mitochondrial
DNA (mtDNA) abundance relative to nuclear DNA (nDNA) (73).
Total DNA was isolated from WAT using a QIAamp DNA Mini Kit
(Qiagen). A 25-mg aliquot of the tissue was homogenized, followed
by overnight digestion in proteinase K at 55°C. Following isolation,
relative amounts of mtDNA and nDNA were compared using quantitative real-time PCR, using 2 ng of the isolated DNA. Primers for
cytochrome b (mtDNA) and ␤-actin (nDNA) were used; the sequences are cytochrome b, 5=-TTGGGTTGTTTGATCCTGTTTCG-3=
and 5=-CTTCGCTTTCCACTTCATCTTACC-3=; and ␤-actin, 5=CAGGATGCCTCTCTTGCTCT-3= and 5=-CGTCTTCCCCTCCATCGT-3=.
Electron microscopy. Adipose tissues were fixed with 3% glutaraldehyde in 0.1 M sodium phosphate buffer (pH 7.4) for 4 h at room
temperature (25°C). The tissues were then postfixed with 1% osmium
tetroxide for 1 h, dehydrated, and embedded in Embed-812 plastic
(Electron Microscopy Sciences). Ultrathin sections were stained with
uranyl acetate and Reynolds lead citrate, and electron micrographs
were taken using a Philips CM10 transmission electron microscope
operating at 80 kV.
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Statistical analyses. Data are means ⫾ SE. Unpaired Student’s
t-test was used for direct comparisons. Statistical analyses for metabolomic data sets were performed using Metaboanalyst 2.0 software. A
P value of ⬍0.05 was considered significant.

mass in HFD-fed mice (Fig. 1, D and E). These results are
typical of this commonly utilized model of diet-induced obesity (30, 54).
To determine how diet affects systemic metabolism, mice
fed either LFD or HFD for 6 wk were placed in metabolic
chambers, and their oxygen consumption (V̇O2), carbon dioxide production (V̇CO2), and physical activity were measured.
As shown in Fig. 1, F and G, average V̇O2 and V̇CO2 values
decreased in HFD-fed mice compared with mice fed a LFD.
The respiratory exchange ratio (RER) was also decreased in
HFD mice vs. mice fed LFD (Fig. 1H). Physical activity,
measured by total beam breaks (Fig. 1I), ambulatory counts
(Fig. 1J), and fine movements (Fig. 1K), was not significantly
different between groups, although the group fed a HFD
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Fig. 1. Effects of high-fat diet (HFD) on
weight gain, adiposity, and systemic metabolism. Male wild-type (WT) C57BL/6J mice
were fed a low-fat diet (LFD; 10% kcal fat) or
HFD (60% kcal fat) for 6 wk, and the following measurements were recorded: mouse
weights during 6 wk of feeding (n ⫽ 20/
group; A); food intake (n ⫽ 7/group; B); water
intake (n ⫽ 7/group; C); representative dualenergy X-ray absorptiometry scan images
(D); %lean mass and %body fat (n ⫽ 10/
group; E); and average oxygen consumption
(V̇O2; F), average carbon dioxide production
(V̇CO2; G), respiratory exchange ratio (RER;
H); total activity level (I), ambulatory counts
(J), and fine movements (n ⫽ 7/group; K).
*P ⬍ 0.05 vs. LFD.
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appeared to show a trend toward decreased activity. Consistent
with our previous results (54), mice fed a HFD also demonstrated worsened glucose and insulin tolerance (Fig. 2) as well
as a significant increase in plasma insulin levels (WT LFD
151 ⫾ 71 pg/ml vs. WT HFD 2,690 ⫾ 593 pg/ml; n ⫽ 3/group,
P ⬍ 0.05).
Robust macrophage infiltration does not occur with 6 wk of
HFD. To examine the effects of HFD on macrophage infiltration, we placed mice on LFD or HFD for 6 or 12 wk and
measured adipocyte size, crown-like structures that are indicative of macrophage infiltration, and the expression of inflammatory genes. As shown in Fig. 3, A–C, mice fed a HFD for 6
and 12 wk showed a three- to fourfold increase in adipocyte
size when compared with LFD controls. Whereas sections of
WAT derived from mice fed a HFD for 12 wk showed obvious
increases in crown-like structures, WAT from mice fed HFD
for 6 wk showed minimal increases in such structures. These
observations suggest that with 6 wk of HFD there is minimal
macrophage accumulation. Indeed, the expression of Emr1, a
marker of macrophages, as well as that of other inflammatory
genes was not changed with 6 wk of HFD (Fig. 3D). Moreover,
the abundance of M1 macrophages in adipose tissue stromal
vascular fractions was not different between mice fed different
diets (F4/80⫹/CD11c⫹/CD301⫺ cells as %F4/80⫹ cells: LFD
37.4 ⫾ 3.5, HFD 45.9 ⫾ 1.8; n ⫽ 9 –10/group, P ⬎ 0.05). Most
likely, the modest, insignificant increase in Tnfa is due to
adipocytes, which have been shown to be capable of producing
TNF␣ (26, 60). In addition, no increase in plasma levels of
inflammatory mediators such as IL-6 were identified at 6 wk of
HFD [IL-6 (pg/ml): LFD, 23.6 ⫾ 7.5; HFD, 18.8 ⫾ 4.2].
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Fig. 2. Glucose and insulin tolerance in mice fed LFD or HFD. After 6 wk of
a LFD or HFD, glucose tolerance and insulin sensitivity were examined:
glucose tolerance test (GTT; A), GTT area under the curve (AUC; B), insulin
tolerance test (ITT) shown as %baseline (C), and ITT AUC (D); n ⫽ 7/group.
*P ⬍ 0.05 and **P ⬍ 0.01 vs. LFD.
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Collectively, these data show that adipocyte size was increased
after 6 wk of HFD, without significant changes in infiltrating
inflammatory cells.
Obesity alters the metabolite profile of adipose tissue. To
examine the effect of obesity on adipose tissue metabolism,
epididymal WAT from mice fed a LFD or HFD for 6 wk was
subjected to unbiased metabolomic analysis. The relative concentration of adipose metabolites was measured by mass spectrometry and queried against the Metabolon reference library.
It is important to note that the composition of adipose tissue
derived from mice fed a LFD differed from mice fed a HFD.
Compared with the LFD group, the protein yield per milligram
wet weight was 43% lower in the adipose tissue of the HFD
group (g protein/mg wet wt: 6 wk LFD, 10.86 ⫾ 1.70; 6 wk
HFD, 6.21 ⫾ 1.28; n ⫽ 10 –12/group). Hence, for metabolomic
analyses, we corrected for this difference in protein content.
Partial least squares-discriminant analysis (PLS-DA) with the
corrected data showed that the LFD samples separate clearly
from HFD samples (Fig. 4A), and cluster analysis showed that
the abundance of several metabolites was associated with diet
(Fig. 4B). Of the 191 metabolites measured, 49 were found to
be significantly different (P ⬍ 0.05) in the WAT of mice fed a
HFD compared with the adipose tissue from mice fed a LFD.
Volcano plot analysis, using data corrected for protein content,
showed significantly higher levels of 34 metabolites and significantly lower levels of 15 metabolites in the adipose tissue of
HFD-fed mice (Fig. 4C and Table 1). Volcano plot analysis
based on uncorrected raw data showed a large skew toward
decreased abundance of most metabolites (Fig. 4C, inset). To
visualize the data in the biological context of metabolic pathways, metabolites that were statistically different in each group
were analyzed using the MetPA tool of Metaboanalyst 2.0
software. The pathways were calculated as the sum of the
importance measures of the matched metabolites normalized
by the sum of the importance measures of all metabolites in
each pathway (55, 81). As shown in Fig. 4D, the highest
pathway impact values were related to linoleic acid metabolism and Phe, Tyr, and Trp metabolism. Branched-chain
amino acids (BCAA), i.e., Val, Leu, and Ile, and pathways
related to taurine metabolism, glycerolipid metabolism, Ala,
Asp, and Glu metabolism, carbohydrate metabolism, and
pyrimidine metabolism also showed relatively high pathway
impact and significant values.
To delineate changes in metabolites further, metabolites
were categorized based on superfamily class, and z-score plots
were constructed. As shown in Fig. 5, the abundance of
multiple members of the lipid superfamily, including those
involved in glycerolipid metabolism and linoleic acid metabolism, was higher. Several carnitine derivatives, with the sole
exception of 3-dehydrocarnitine, were higher in abundance as
well. In the amino acid superfamily, the levels of nonessential
amino acids Glu, Gln, and Asp were elevated, and those of
essential amino acids Phe, Leu, and Val were lower. Notably,
the organic osmolytes taurine, hypotaurine, and creatine were
more abundant. In the HFD group, levels of the Krebs cycle
intermediate succinate were higher; levels of malate were
higher as well, although pantothenate, a precursor to CoA, was
less abundant. Although both glucose and maltose levels were
higher, phosphorylated sugars were diminished. Plasma 1,5anhydroglucitol (1,5-AG), which is present in most organs and
tissues and has been shown to decrease with loss of glycemic
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control (67, 83), was diminished in abundance, which is in
agreement with insulin resistance in skeletal muscle and liver
occurring at 6 wk of HFD (30). Interestingly, the pyrimidine
monophosphates cytidine-5=-monophosphate (CMP) and uridine monophosphate (UMP), as well as the purine inosine-5=monophosphate (IMP), were elevated in WAT from HFD-fed
mice. A graphic illustration of these changes, placed into
context of known pathways of intermediary metabolism, is
shown in Fig. 6.
Effects of obesity on oxygen consumption and mitochondrial
remodeling in WAT. The changes in energy metabolism found
in our metabolomic analyses suggested that HFD might have
altered adipose tissue bioenergetics. Importantly, these changes
occurred in the absence of inflammatory cell infiltration (see
Fig. 3), which could otherwise confound adipocyte-specific
changes in metabolism. To determine how obesity affects
mitochondrial function, WAT explants from mice fed a LFD or
HFD were subjected to extracellular flux analysis. As shown in
Fig. 7, A and B, the apparent basal mitochondrial OCR of

Il6

Arg1

Il10

Ym1

Emr1

Hif1a

adipose tissue derived from mice fed a LFD was approximately
twofold higher when compared with adipose explants derived
from HFD-fed mice (P ⬍ 0.05); however, after correction for
protein content, there was no difference in mitochondrial
oxygen consumption. Nevertheless, explants derived from
mice fed a HFD responded more strongly to FCCP (Fig. 7C).
Although citrate synthase activity was lower by ⬎50% in
WAT derived from these mice (Fig. 7D), relative abundance of
mtDNA, as assessed by qPCR of mtDNA normalized to
nDNA, was not affected with 6 wk of HFD (Fig. 7E).
The observed changes in metabolite profile, increased mitochondrial responsiveness to FCCP, and diminished citrate
synthase activity suggested that HFD might affect the expression of genes associated with metabolic activity. Indeed, the
expression of Cox7a1, a subunit of cytochrome oxidase, was
more than twofold higher in adipose tissue from mice fed a
HFD, whereas the expression of Pgc1a, Sirt3, and Pdk4 was
diminished (Fig. 8A), indicating mitochondrial remodeling
despite preserved basal mitochondrial activity.
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To further understand how WAT mitochondria change with
obesity, we assessed the relative abundance of several mitochondrial complex proteins as well as mitochondrial matrix
proteins. Although no changes in mitochondrial protein abundance were observed at 6 wk of HFD, the protein levels of
NDUFB8, SDHB, and COX4I1 subunits of complexes I, II,
and IV, respectively, were diminished significantly by 12 wk of
HFD (Fig. 8, B–E). The levels of the matrix proteins ALDH2
and Sirt3 showed similar trends, with ALDH2 being significantly lower after 12 wk of HFD.
Assessment of adipose tissue ultrastructure. To determine
subcellular changes that occur in adipose tissue of nutrientstressed mice, we examined adipocyte ultrastructure using electron microscopy. As shown in Fig. 9A, adipose tissue from mice

fed a LFD showed mitochondria with three distinct morphologies:
a round morphology of small size that was located near the
nucleus (Fig. 9A, images i and ii), a typical elongated shape up to
⬃0.7 m in length located in small protrusions along the adipocyte cell membrane (Fig. 9A, image iii), and long mitochondria
(3 m and above), which were located in juxtaposition to the fat
locule (Fig. 9A, image iv). In adipocytes derived from HFD-fed
mice, autophagosomes, defined by a double-membrane and
comprising cytoplasmic constituents, were found next to
mitochondria (Fig. 9B, image i), and large vacuoles of
electron-dense material were found adjacent to autophagosomes (Fig. 9B, images ii and iii). In addition, many mitochondria in adipose tissue from HFD-fed mice appeared to
be undergoing fission (Fig. 9B, images iv and v).
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Table 1. List of adipose tissue metabolites that changed significantly in high-fat-fed mice
Metabolite

Fold Change

P Value

FDR

Stearoyl sphingomyelin*
Glycerophosphoethanolamine*
Succinate*
Inosine 5=-monophosphate
Uridine monophosphate (5= or 3=)
Dihomo-linoleate (20:2n6)
Pelargonate (9:0)
Cytidine 5=-monophosphate*
Isobar: fructose 1,6-diphosphate, glucose 1,6-diphosphate,
myo-inositol 1,4 or 1,3-diphosphate*
Maltose
Docosapentaenoate (22:5n3)
Glutamate*
Glucose
Azelate (nonanedioate)
Dihomo-linolenate (20:3n3 or n6)
Stearate (18:0)
Arachidonate (20:4n6)
Deoxycarnitine
Glycerophosphorylcholine
Hypotaurine
12-Hydroxyeicosatetraenoic acid
Acetylcarnitine
Margarate (17:0)
Aspartate
Creatine
Malate
Linoleate (18:2n6)
Palmitoyl ethanolamide
Propionylcarnitine
Taurine
Glutamine
Choline phosphate
Citrulline
Cholesterol
Leucine*
Tyrosine*
Pantothenate
Mead acid (20:3n9)
Phenylalanine
Valine
3-Dehydrocarnitine
1,5-Anhydroglucitol
Glucose 6-phosphate
Histamine
Ergothioneine
N-acetylmethionine*
Mannose 6-phosphate*
Glycerate*
Glycylleucine*

2.8
2.7
2.34
2.27
2.26
2.03
2.02
1.95

0.000542
0.000000
0.000139
0.016131
0.009442
0.011868
0.030984
0.000214

0.010414
0.000014
0.006385
0.088492
0.064744
0.071209
0.14203
0.006839

1.87
1.86
1.83
1.81
1.8
1.75
1.75
1.74
1.68
1.64
1.64
1.62
1.61
1.54
1.51
1.47
1.46
1.45
1.42
1.38
1.37
1.33
1.32
1.32
1.29
1.28
0.79
0.78
0.73
0.66
0.62
0.6
0.58
0.56
0.51
0.46
0.45
0.35
0.33
0.07
0.05

0.000166
0.03107
0.033432
0.000111
0.005764
0.001215
0.006864
0.003972
0.001536
0.000539
0.005243
0.024921
0.036945
0.000362
0.046138
0.003862
0.000666
0.008981
0.026561
0.02444
0.048868
0.001968
0.000372
0.011199
0.002367
0.002251
0.005401
0.042828
0.049223
0.028737
0.011086
0.00483
0.013332
0.010344
0.045306
0.017878
0.000163
0.002013
0.013998
0.008323
0.000986

0.006385
0.14203
0.14928
0.006385
0.046111
0.01795
0.052713
0.038131
0.021059
0.010414
0.045087
0.12592
0.16121
0.008923
0.18455
0.038131
0.01162
0.063867
0.13076
0.12592
0.18902
0.024159
0.008923
0.06936
0.025244
0.025244
0.045087
0.18273
0.18902
0.13794
0.06936
0.044159
0.077568
0.068482
0.18455
0.095349
0.006385
0.024159
0.079048
0.061462
0.015774

FDR, false discovery rate. Wild-type mice were fed a low-fat (LFD) or high-fat diet (HFD) for 6 wk. Epididymal adipose tissue was then subjected to liquid
chromatography or gas chromatography mass spectrometric analysis. Raw spectral values from white adipose tissue (WAT) of HFD-fed mice were corrected on
the basis of mean difference in protein content (per mg wet wt) compared with WAT from LFD-fed mice. Adipose tissue metabolites in HFD-fed mice that were
ⱖ25% changed in abundance and significantly different (P ⬍ 0.05) compared with LFD-fed mice are shown; n ⫽ 7 mice/group. *Metabolites that were
significant even when ⫾2 SE was applied in protein correction.

Effects of HFD on autophagy. Changes in mitochondrial proteins, along with the ultrastructural alterations found to occur in
the adipose tissue, suggest that HFD may promote mitochondrial
remodeling and activate mitophagy in WAT. To examine this
possibility, we measured markers of mitophagy and autophagy in
adipose tissues from mice fed a LFD or HFD for 6 wk. Levels of
the E3 ubiquitin ligase Parkin, which has been shown to accumulate in mitochondria destined for degradation (24), were 2.3-fold
higher with 6 wk of HFD and nearly twofold higher after 12 wk
of HFD (Fig. 10, A and B). Furthermore, the kinase Pink1, critical
for identifying mitochondria destined for autophagy (24), was also

nearly 40% higher in the HFD groups. In combination with the
presence of autophagosomes and mitochondrial alterations observed by EM (Fig. 9), this observation suggests that metabolic
remodeling of adipocytes in the expanding adipose organ may be
related to autophagy. To address this possibility, we measured
changes in protein indicators of autophagy. As shown in Fig. 10,
C–H, levels of p62 and LC3-I were diminished significantly, and
the LC3-II/LC3-I ratio was more than twofold higher in mice fed
a HFD for 6 wk compared with those placed on LFD. However,
there was no significant difference in total protein abundance of
protein-ubiquitin and LC3-II.
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DISCUSSION

The results of this study demonstrate coordinated restructuring of adipose tissue metabolism during adipocyte hypertrophy. Using metabolomics analysis, we identified several
HFD-induced changes in key metabolites involved in energy, carbohydrate, nucleotide, lipid, and amino acid metabolism. Importantly, these changes were relatively independent of inflammatory cell infiltration, and the data were corrected for adipocyte content, both of which help eliminate
confounding features related to tissue and adipocyte composi-
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tion. Our analysis showed an early decrease in citrate synthase
activity that coincided with reduced expression of Pgc1a,
although mitochondrial abundance was not affected. Ultrastructural and immunological evidence suggested that whitening of the adipose tissue, evident after 12 wk of HFD, may also
be related to autophagy, which appears to occur early after
adipocytes attain near-maximum size. Taken together, these
results reveal that conditions of nutrient excess promote progressive metabolic remodeling, decreased capacity for mitochondrial biogenesis, and potential activation of the autophagic
program in WAT.
The major goal of this study was to understand how HFD
affects adipose tissue biology and metabolism. This is important because key metabolic changes that occur during adipocyte hypertrophy could be targets for antiobesity or insulinsensitizing therapies. We found that 6 wk of HFD feeding led
to a profound increase in fat mass, which was accompanied by
a decrease in systemic V̇O2, V̇CO2, and RER and insulin
resistance. Although adipose tissue inflammation was evident
by the 10th to 12th wk of HFD (41, 66), we found no
significant increase in inflammatory cell infiltration with 6 wk
of HFD (e.g., see Fig. 3 and Refs. 30 and 41). This lack of
extensive tissue infiltration by energetic inflammatory cells
allowed us to examine HFD-induced changes specific to the
adipose tissue.
Moreover, in our metabolic measurements, we accounted for
changes in the composition of the adipocytes themselves.
Because white adipocytes expand by storing triglycerides in
the central lipid droplet, an equivalent tissue mass of WAT
from a HFD-fed mouse comprises fewer cells (and more
triglyceride) than adipose tissue from a LFD-fed mouse. Thus,
normalization of metabolite levels by wet weight alone could
lead to erroneous conclusions. An example of this is shown in
Figs. 4 and 6, where uncorrected values indicate that most
metabolites are decreased in WAT from HFD-fed mice (Fig.
4C, inset) and that mitochondrial OCR is diminished in adipocytes from the obese mice (Fig. 7, A and B). Correcting for
protein content in samples from HFD-fed mice normalized the
distribution of metabolic changes and rectified the leftward
skew caused by decreased adipocyte content. Similarly, when
values were normalized for protein content (rather than mg wet
wt), there was no difference in tissue oxygen consumption
between explants from LFD and HFD groups. This indicates
that with 6 wk of HFD there was no change in basal mitochondrial oxygen consumption per adipocyte.
Our metabolic profiling indicates that HFD affects several
metabolic pathways. In mice placed on HFD for 6 wk, we
found significant changes in lipid, amino acid, energy, nucleotide, and carbohydrate metabolism. Higher levels of several
fatty acids and lipid metabolites belonging to the linoleic acid
metabolism subfamily were observed in WAT from HFD-fed
mice. In this tissue there was also a higher abundance of
arachidonic acid as well as metabolites involved in arachidonic
acid synthesis, including linolenic acid and dihomo-linolenic
acid, which indicates a coordinated upregulation of this pathway. WAT from HFD-fed mice also contained higher levels of
the eicosanoid 12-hydroxyeicosatetraenoic acid (12-HETE),
which is formed from arachidonate by 12/15-lipoxygenase
(12/15-LO). Interestingly, 12/15-LO is upregulated in white
adipocytes of both HFD-fed C57BL/6J mice (10) and Zucker
obese rats (11). Thus, upregulation of 12/15-LO and increased

AJP-Endocrinol Metab • doi:10.1152/ajpendo.00271.2013 • www.ajpendo.org
Downloaded from journals.physiology.org/journal/ajpendo (197.248.065.033) on March 17, 2022.

E270

METABOLIC REMODELING OF ADIPOSE TISSUE
Glucose

Linoleate

Maltose

Choline

G6P
Choline phosphate

GPC#

GPE
Dihomo-linolenic acid
F6P

M6P

F-1,6-P2*

DHAP

Phosphatidylcholine
Arachidonate

G3P

Aspartate

Fig. 6. Illustration of metabolite changes in
adipose tissue of obese mice. Metabolic
changes in adipose tissue that occur with
HFD are shown in the context of known
metabolic pathways. In gray are those metabolites that increased, and in black (and
underlined) are those metabolites that were
diminished in obese mice. 12-HETE, 12hydroxyeicosatetraenoic acid; CoA, coenzyme
A; CMP, cytidine 5=-monophosphate; DHAP,
dihydroxyacetone phosphate; FAs, fatty acids;
F6P, fructose-6-phosphate; F-1,6-P2, fructose1,6-bisphosphate; G3P, glycerol 3-phosphate;
G6P, glucose 6-phosphate; GA3P, glyceraldehyde-3-phosphate; GPC, glyerophosphorylcholine; GPE, glycerophosphoethanolamine;
IMP, inosine 5=-monophosphate; UMP, uridine monophosphate (5= or 3=). *Isobaric entity; metabolite identity is unclear from the data
and could be either F-1,6-P2, glucose-1,6diphosphate, or myo-inositol 1,4- or 1,3diphosphate. #Organic osmolytes that changed
in abundance.

Valine

GA3P
β-alanine Pantoate
12-HETE

Triglyceride

Pyruvate
CoA

Acetylcarnitine

FA-CoA

Acetyl-CoA

FAs

Citrate
Aspartate

Krebs
cycle

Phenylalanine
Tyrosine

Fumarate

Aspartate
UMP
IMP
CMP

Isocitrate

Oxaloacetate

Malate

CoA

Pantothenate

α-ketoglutarate

Precursors

Glutamate

Glutamine

Succinyl-CoA
Succinate
Propionyl-CoA

Deoxycarnitine

Propionylcarnitine

Carnitine
Valine
Leucine

3-dehydrocarnitine

N-acetylmethionine

Cysteine

production of its product (12-HETE) are consistent features of
hypertropic WAT. This may be particularly significant in
mediating adipose tissue dysfunction because two separate
studies have shown that genetic deletion of 12/15-LO prevents
HFD-induced adipose tissue inflammation and insulin resistance (42, 59).
The elevated levels of glycerophosphoethanolamine in WAT
from obese mice could be due to an increase in the breakdown
of phosphatidylethanolamine or a decrease in its rate of hydrolysis. Previous studies have shown that glycerophosphoethanolamine is hydrolyzed by enzymes such as glycerophosphodiester phosphodiesterase to form glycerol 3-phosphate (G3P)
(84), which is required for triglyceride synthesis and thus
would likely be in high demand in expanding adipocytes (46).
Glycerophosphorylcholine, which was elevated in WAT from
HFD-fed mice, could also be utilized to form G3P. However,
a major function of glycerophosphorylcholine in the cell is to
act as an organic osmolyte (19), suggesting that there might be
an increase in osmotic stress in hypertrophic adipocytes. This
view is supported by our observation that the levels of several

Hypotaurine#

Taurine #

Gray= increased
Black = decreased
*isobar
#osmolyte

major osmolytes such as taurine, hypotaurine, and creatine
were higher in WAT from obese mice. Changes in osmolality
could trigger a form of cell death called pyroptosis (4), which
has been linked with inflammasome activity (57). Interestingly,
the NLRP3 inflammasome is activated by cholesterol crystals,
and, consistent with previous observations in hypertrophied
adipocytes (20, 85), our analyses also showed an elevation of
cholesterol in adipose tissue of obese mice. Collectively, these
observations suggest an early increase in key metabolic instigators that could contribute to osmotic stress and inflammation
in adipose tissue.
The HFD-induced increase in stearoyl sphingomyelin could
further prime adipocytes for inflammation and metabolic dysfunction. Sphingomyelin (d18:1/18:0), which in humans is the
only membrane phospholipid not derived from glycerol, is a
type of sphingolipid found in cell membranes that consists of
oleic acid attached to the C1 position and stearic acid attached
to the C2 position. Genetic deletion of enzymes involved in
sphingomyelin synthesis has been shown to protect against
diet-induced obesity and insulin resistance (35, 38), and the
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breakdown of sphingomyelin could yield significant amounts
of ceramide, which inhibits insulin signaling (12). Hence, the
elevated levels of sphingomyelin observed in our study could
prime adipocytes to release significant amounts of ceramide,
which has been shown to be increased by 300% in both the
plasma and the adipose tissue by HFD (61). Although ceramide
levels were not measured in our analyses, we did observe a
decrease in Pgc1a expression and a decrease in citrate synthase
activity, both of which can be regulated by ceramide (56, 71).
However, further studies are required to determine whether
changes in mitochondrial biogenetic capacity and citrate synthase activity are related to high levels of stearoyl sphingomyelin.
Our metabolomic data suggest significant changes in intermediary metabolism related to energy expenditure and fat
storage. We found that many carnitine derivatives were increased in WAT from HFD-fed mice. These include acetylcarnitine, proprionylcarnitine, and deoxycarnitine, although 3-dehydrocarnitine, an intermediate in carnitine degradation, was
diminished. These changes suggest the presence of a “flooded”
pool of adipocyte metabolites, which could be used either for

energy provision or, more likely, as a temporary repository for
substrates for fatty acid synthesis. In other tissues such as the
heart, acetylcarnitine functions as a buffer of the acetyl-CoA
pool, although it could be used as an energetic substrate as well
(58). Similarly, the propionylcarnitine could buffer the propionyl CoA pool (63). Thus, it appears that, in expanding adipocytes, short-chain acylcarnitine pools could help buffer excess carbon until it is assimilated into fatty acids for triglyceride storage.
The observation that tissue levels of BCAAs such as leucine
and valine were decreased, whereas propionylcarnitine and
succinate levels were increased with HFD, suggests an increase
in BCAA catabolism. Catabolism of BCAAs results in the
formation of both acetyl-CoA and succinyl-CoA, and the latter
can be converted to succinate, which in our analysis was
elevated in WAT from HFD-fed mice. Thus, it is likely that in
hypertrophic adipocytes there is increased utilization of
BCAAs. In contrast to the decrease in BCAAs, we found that
levels of Gln and Glu were increased with HFD. This increase
may be particularly important given the multifaceted uses of
glutamine, e.g., in anaplerotic metabolism, as a nitrogen donor
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in anabolic processes as well as a precursor for glutathione
synthesis (69, 80). In addition, Gln and Asp are required for
synthesis of several nucleotides, such as IMP, UMP, and CMP,
all of which were increased in these studies. Interestingly,
adipose tissue is a major site of glutamine synthesis, and its
uptake can be regulated by changes in osmolality as well as by
insulin (49).
Although there is a clear relationship between amino acids,
insulin resistance, and obesity in animal models and humans
(1, 13, 39), the mechanistic basis of this link is less clear.
BCAA metabolism in adipose tissue modulates plasma BCAA
levels (23), and interestingly, increasing circulating BCAAs in
mice by preventing BCAA catabolism prevents diet-induced
obesity and insulin resistance in mice (62), whereas feeding
BCAAs to HFD-fed rats increases insulin resistance (39).
Although further studies are required to test the full significance of such metabolic changes in BCAAs and other amino
acid pathways, it is possible that changes in amino acid
catabolism and downstream metabolites have novel roles in
adipose tissue biology such as the regulating of lipid storage
and release. This possibility is supported by a recent report
showing that succinate, which can be derived from BCAA

breakdown, inhibits lipolysis by activating Gpr91 (a succinate
receptor) (48).
Metabolites related to glucose metabolism were also
markedly affected by HFD. We found a nearly 50% decrease
in the abundance of 1,5-AG in WAT samples from HFD-fed
mice. Plasma 1,5-AG is a validated marker of short-term
glycemic control and has been suggested to be in equilibrium in tissue and plasma pools (67, 83). Hence, although 6
wk of HFD does not appear to significantly affect fasting
blood glucose levels (54), the decreased abundance of
1,5-AG is consistent with systemic insulin resistance and
poor glycemic control (30). With respect to glycolysis,
glucose 6-phosphate was decreased, and adipose tissue glucose was increased, suggesting that hexokinase might be a
major rate-limiting step in the provision of glucose carbons
required for triglyceride synthesis. Further evidence of
changes in glucose metabolism is shown by diminished pdk4
expression, which regulates pyruvate dehydrogenase activity. This decrease in pdk4 could potentially promote glyceroneogenic formation of G3P (8) via cataplerosis (45).
Interestingly, although we observed no change in basal
mitochondrial OCR when corrected for protein content, WAT
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Fig. 9. Ultrastructure of white adipose tissue from
lean and obese mice. Representative transmission
electron micrographs of epididymal adipose tissues derived from mice fed a LFD or HFD for 6
wk. A: ultrastructure of mitochondria in adipose
tissues from LF-fed mice. Image i: micrograph of
adipocytes in areas close to the nucleus; image
ii: a higher magnification of image i; image iii: a
cytosolic compartment containing a mitochondrion found protruding into the fat locule; image
iv: an elongated mitochondrion in juxtaposition to
the fat locule. B: ultrastructure of adipose tissue
derived from HFD-fed mice. Image i: an elongated
mitochondrion next to an autophagosome; image
ii: an autophagosome in close proximity to a vacuole containing electron-dense material; image
iii: a higher magnification of image ii; image
iv: protrusion of cytosolic compartment containing
an atypical mitochondrion; image v: mitochondrion that appears to be undergoing fission. *Autophagosomes. Small arrows indicate collagen. M,
mitochondria; N, nucleus; LD, vacuole lipid droplet.

from HFD-fed mice showed an increased response to FCCP.
We speculate that once metabolic restraint due to ⌬p is lifted
(by addition of uncoupler), the increased substrate available for
oxidative phosphorylation, e.g., succinate, malate, glutamate,
or short-chain acylcarnitines, results in increased rates of
oxygen consumption. Also, in data sets corrected for protein
content, there was a trend toward an increased rate of nonmitochondrial oxygen consumption, which might suggest an
increase in adipocyte superoxide production due to cytosolic
oxidase activity (9, 24). This possibility is consistent with
previous studies showing an increase in oxidative stress in
adipose tissue of obese mice, which is caused predominantly
by an increase in NADPH oxidase and downregulation of
antioxidant enzymes (15, 18, 36, 37, 43).
Further support for coordinated remodeling of mitochondrial
and cytosolic metabolism is provided by the observation that
expression of Cox7a1 was increased in the adipose tissue of
obese mice. A similar increase in Cox7a1 gene has been shown
in the WAT of fattening cattle (3), although the implications of
this increase are currently unclear. Cox7a1 is considered to be

a heart- and muscle-specific subunit of cytochrome oxidase,
but it is also present in brown adipose tissue; these tissues are
highly metabolic organs capable of utilizing large amounts of
substrate. Thus, it is possible that the increase in Cox7a1 may
be an adaptive response to dissipate excessive energy in the
adipocyte. The decrease in citrate synthase activity, which
provides additional evidence for remodeling of mitochondrial
metabolism during adipocyte hypertrophy, is similar to that
observed in db/db mice, where citrate synthase activity is
diminished remarkably with no change in mtDNA/nDNA (52).
Why citrate synthase decreases in expanding adipocytes is
currently unclear; however, it could be an adaptation to prevent
excessive influx of carbon into the Krebs cycle, which would
be consistent with the view that during obesity there is an
overall shift in metabolism from energy provision to lipid
storage.
The notion that HFD remodels mitochondrial metabolism in
adipocytes is further supported by diminished mitochondrial
biogenetic capacity and later decreases in electron transport
chain protein abundance. With 6 wk of HFD, mitochondrial
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Fig. 10. Evidence for activation of mitophagy in white
adipose tissue of obese mice. Immunoblot analysis of
markers of mitophagy and autophagy. A: Western blots of
Parkin and Pink 1 in adipose tissues from mice fed a LFD
or HFD for 6 (left) or 12 wk (right). B: quantification of
Parkin and Pink1 abundance from E; n ⫽ 4/group.
C: representative Western blots of ubiquitinated proteins,
p62, and LC3 in mice fed a LFD or HFD for 6 wk.
D–H: quantification of protein-ubiquitin abundance, p62,
LC3-I, LC3-II abundance, and LC3-II/LC3-I ratio; n ⫽
10/group. *P ⬍ 0.05 vs. LFD.
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abundance per se was not affected; however, we did find a
significant decrease in Pgc1a expression, which was followed
by loss of mitochondrial protein abundance after 12 wk of
HFD. This relatively late decrease in mitochondrial protein
abundance may also be due to early changes in mitochondrial
metabolism that promote removal of mitochondria by autophagy. Autophagy has been shown previously to be increased in adipocytes from obese humans and mice (28, 33,
44). Consistent with those studies, our biochemical results
show an increase in the LC3-II/LC3-I ratio and a decrease in
p62, the combination of which would appear to be consistent
with an increase in autophagic flux (5, 31). Ultrastructural data
showing autophagosomes and vacuolated structures containing
electron-dense material further suggest changes in autophagy
consistent with its activation. However, a limitation of this
study is that autophagic flux was not measured directly, making it difficult to ascribe with certainty directional changes to
the autophagy pathway. Nevertheless, an activation of autophagy in adipose tissue would be expected to decrease the
abundance of both LC3-I and p62 (32, 64, 76, 86), which is

LC3-I

G

LC3-II

H

LC3-II/LC3-I

consistent with our results. Hence, our cumulative data are
supported by evidence in the literature and suggest that autophagy is activated by HFD. Although we cannot clearly
distinguish whether mitochondria are removed by autophagy,
the increase in key proteins involved in mitophagy, Parkin and
Pink1 (24, 74), would be consistent with a significant role of
mitophagy in mediating mitochondrial remodeling and turnover in the WAT of obese mice.
In summary, in this study we identified key metabolic
changes that occur during WAT expansion. These coordinated
changes occur before the infiltration of inflammatory cells and
include loss of mitochondrial biogenetic capacity, dysregulation of lipid, amino acid, glucose, nucleotide, and amino acid
metabolism, changes in mitochondrial gene expression and
protein abundance, and evidence of alterations in autophagy
and possibly mitophagy. Our results are consistent with the
view that constant nutrient excess shifts adipocyte metabolic
activity from energy provision to lipid storage. We speculate
that the decrease in mitochondrial biogenetic capacity and later
removal of mitochondria may also be a response to limit lipid
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oxidation and oxidative stress and to promote fat storage.
Further studies are required to assess the significance of each of
the metabolic alterations and to test whether therapeutically
targeting these pathways is a gainful strategy for preventing
obesity and its unfortunate metabolic consequences.
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